Six Firms Advise on First Pharmaceutical Megadeal of 2016

Cravath, Jones Day, Kirkland & Ellis, Ropes & Gray, Slaughter and May and Skadden have grabbed roles on the proposed $32 billion merger between rare disease drug makers Shire plc and Baxalta Inc.

Sign up for a free Law.com trial now!

Law.com's Elite 15-day trial gives you:

  • All access pass to legal news across ALM's Network
  • News by Practice Area, available exclusively on Law.com
  • The free Law.com InPractice digital newsletter
  • Personalized legal news on the Law.com mobile App

During and after your trial, you'll receive the benefits of an ALM digital membership, including a subscription to the Law.com Newswire digital newsletter.